Immunic Inc
Statements
Cash Flow
Immunic Inc (IMUX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -31 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.9 | -9.1 | -11 | -10 | -9.4 | -9.9 | -13 | -12 | -13 | -4.7 | -3.7 | -13 | -6.0 | -6.3 | -11 | -9.2 | -12 | -14 | -13 | -29 | -18 | -24 | -21 | -16 | -14 | -15 | -20 | -20 | -17 | -14 | -24 | -17 | -21 | -23 | -22 | -25 | -20 | -19 | -17 | -31 | -88 | |
| 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 1.4 | 1.3 | 1.3 | 1.2 | 1.2 | 1.8 | 1.6 | 1.8 | -0.3 | 0.6 | 6.1 | -0.1 | 0.2 | 0.3 | 0.4 | 0.4 | 0.7 | 1.3 | 1.6 | 1.5 | 1.4 | 1.5 | 2.1 | 2.1 | 1.9 | 1.9 | 2.0 | 1.8 | 1.7 | 1.6 | 2.8 | 1.9 | 1.9 | 2.0 | 2.0 | 1.9 | 3.6 | 1.3 | 4.5 | 6.8 | 16 | |
| 1.4 | 1.4 | 1.3 | 1.2 | 1.2 | 2.1 | 1.6 | 2.1 | 1.0 | 0.5 | 6.1 | -0.1 | -0.1 | 1.9 | 0.4 | 0.4 | 0.7 | -1.2 | 4.1 | 0.9 | 2.7 | 11 | 2.2 | 4.0 | 4.0 | 35 | 2.5 | 1.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.5 | 0.9 | 0.1 | 0.9 | 1.6 | 2.4 | -0.5 | -1.9 | -2.3 | -2.8 | -0.6 | -4.2 | 2.4 | 1.1 | -2.9 | 1.9 | 0.3 | -1.6 | 8.9 | -12 | -1.0 | -5.1 | -2.1 | 2.1 | 3.6 | 6.0 | 3.2 | 2.1 | 3.7 | 6.1 | -4.0 | 2.9 | 1.6 | 0.1 | 1.6 | 0.2 | 1.7 | -1.7 | 11 | -5.1 | 5.6 | |
| 0.3 | 0.1 | 0.3 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.2 | 0.3 | |
| -0.1 | -0.1 | -0.3 | -0.1 | -0.2 | -0.1 | -0.2 | -0.2 | -0.3 | 0.2 | 0.0 | 9.3 | 1.2 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -9.6 | 5.3 | 4.3 | 0.0 | -0.2 | 0.0 | -0.2 | -0.1 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | -0.2 | -0.3 | |
| – | – | – | – | – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -8.8 | 12 | 38 | -0.1 | -0.2 | 0.5 | – | 0.0 | 0.0 | 0.0 | 21 | 30 | 0.3 | 4.6 | 0.6 | – | 97 | 8.1 | – | – | 42 | 0.1 | 30 | 0.1 | – | 0.1 | 0.1 | 0.1 | – | 0.1 | – | – | – | 0.1 | – | 0.1 | – | 0.1 | – | – | – | |
| 0.0 | – | – | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | -0.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.4 | 1.1 | 38 | -0.2 | -0.2 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 30 | 0.2 | 4.7 | 0.6 | 39 | 97 | 8.1 | 8.6 | 42 | 42 | 0.8 | 30 | 10 | 56 | 56 | 0.1 | 0.1 | 0.3 | 0.6 | 74 | 0.0 | 0.0 | 0.1 | 0.0 | 66 | 0.0 | 0.1 | 189 | 0.1 | 189 | |
| -5.5 | -8.1 | 27 | -10 | -9.8 | -9.5 | -13 | -13 | -13 | -4.5 | -3.7 | 27 | -5.7 | -1.1 | -11 | 30 | 85 | -5.7 | -13 | -28 | 23 | -24 | 8.8 | -7.6 | -15 | 34 | -14 | -15 | -18 | -13 | 51 | -18 | -21 | -23 | -21 | 41 | -20 | -20 | 171 | -32 | 100 | |
| -8.2 | -9.2 | -11 | -10 | -9.6 | -10 | -13 | -13 | -13 | -4.7 | -3.7 | -13 | -6.0 | -6.3 | -11 | -9.3 | -12 | -14 | -13 | -29 | -18 | -24 | -21 | -16 | -14 | -15 | -20 | -20 | -17 | -14 | -24 | -17 | -21 | -23 | -22 | -25 | -20 | -19 | -17 | -31 | -88 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.